The discussion around the interchange of biological drugs has been going on for a long time and still raises a lot of controversy and doubts. On June 18, 2018, a scientific seminar "Substitution-Substitute of Biological Drugs" was held, devoted to this issue. One of the speakers was Monika Duszyńska, who discussed the EU guidelines and selected regulatory agencies regarding the interchange and substitution of biological drugs.